Precision Biosciences (DTIL) EBITDA Margin (QoQ) (2018 - 2026)
Precision Biosciences (DTIL) EBITDA Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,030.00 |
| Dec 31, 2025 | 15.90 Mn |
| Sep 30, 2025 | -3.74 Mn |
| Jun 30, 2025 | -4.53 Mn |
| Mar 31, 2025 | -7.24 Mn |
| Dec 31, 2024 | -20,078.00 |
| Sep 30, 2024 | -374,197.00 |
| Jun 30, 2024 | 7,220.00 |
| Mar 31, 2024 | 18,775.00 |
| Dec 31, 2023 | -11,734.00 |
| Sep 30, 2023 | -7,842.00 |
| Jun 30, 2023 | 13,628.00 |
| Mar 31, 2023 | -3,784.00 |
| Dec 31, 2022 | 8,506.00 |
| Sep 30, 2022 | 57,434.00 |
| Jun 30, 2022 | 5,042.00 |
| Mar 31, 2022 | -33,941.00 |
| Dec 31, 2021 | -43,666.00 |
| Sep 30, 2021 | -7,946.00 |
| Jun 30, 2021 | 14,608.00 |